Purpose/Objectives: To determine the severity and trajectory of constipation among patients with cancer from opioids and/or vinca alkaloids.
Design: Exploratory, descriptive.
Setting: Moffitt Cancer Center, a National Cancer Institute-designated comprehensive cancer center in Tampa, FL.
Sample: 400 patients at risk for developing medication-induced constipation from opioids, vinca alkaloids, or both.
Methods: Patients' baseline data included the Constipation Assessment Scale (CAS), the constipation item from the Memorial Symptom Assessment Scale (MSAS) for intensity and distress, and the laxative interview. Following the interview, the medical chart was reviewed for clinical and demographic data. Patients were asked about constipation (CAS) and laxatives consumed (laxative interview) during eight weekly telephone calls.
Main Research Variables: Constipation presence, intensity, and distress.
Findings: At baseline, 63% of patients reported some level of constipation. During the eight weeks, constipation fluctuated with scores ranging from 0-16, with the opioid-only group showing a small but statistically significant decrease in intensity. Constipation intensity and distress on the MSAS were significantly correlated (r = 0.76; p = 0.000).
Conclusions: The majority of the sample reported constipation that ranged from mild to severe, persisted over time, and caused symptom distress. Therefore, healthcare providers in the cancer center likely were neither adequately managing the medication-induced constipation nor apparently teaching patients to manage it themselves.
Implications for Nursing: National Comprehensive Cancer Network guidelines support the importance of managing medication-induced constipation. However, guidelines are not being followed in many cases; therefore, more focus is needed on constipation in clinical and educational settings as well as more research.
Knowledge Translation: Patients receiving opioids and vinca alkaloids are at risk of constipation. Currently, medication-induced constipation is poorly managed. Managing constipation may lessen symptom distress, thereby improving quality of life in these patients.
American Cancer Society. (2012). Cancer facts and figures, 2012. Atlanta, GA: Author.
Cameron, J. C. (1992). Constipation related to narcotic therapy: A protocol for nurses and patients. Cancer Nursing, 15, 372-377.
Canty, S. L. (1994). Constipation as a side effect of opioids. Oncology Nursing Forum, 21, 739-745.
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373-383. doi:10.1016/0021-9681(87)90171-8
Glare, P., & Lickiss, J. N. (1992). Unrecognized constipation in patients with advanced cancer: A recipe for therapeutic disaster. Journal of Pain and Symptom Management, 7, 369-371. doi:10.1016/0885-3924(92)90092-V
Hoekstra, M. A., de Vos, R., van Duijn, R., Schadé, E., & Bindels, P. J. (2006). Using the Symptom Monitor in a randomized controlled trial: The effect on symptom prevalence and severity. Journal of Pain and Symptom Management, 31, 22-30. doi:10.1016/j.jpainsymman.2005.06.014
Hsieh, C. (2005). Treatment of constipation in older adults. American Family Physician, 72, 2277-2284.
Lehne, R. A. (2007). Pharmacology for nursing care. St. Louis, MO: Saunders-Elsevier.
Lenz, E. R., Pugh, L. C., Milligan, R. A., Gift, A., & Suppe, F. (1997). The middle-range theory of unpleasant symptoms: An update. Advances in Nursing Science, 19(3), 14-27.
Levy, M. H. (1991). Constipation and diarrhea in cancer patients. Cancer Bulletin, 43, 412-422.
Littell, R. C., Milliken, G. A., Stroup, W. W., Wolfinger, R. D., & Schabenberger, O. (2006). SAS for mixed models (2nd ed.). Cary, NC: SAS Press.
McMillan, S. C. (2002). Presence and severity of constipation in hospice patients with advanced cancer. American Journal of Hospice and Palliative Care, 19, 426-430. doi:10.1177/104990910201900616
McMillan, S. C., & Rivera, H. R. (2009). The relationship between depressive symptoms and symptom distress in patients with cancer newly admitted to hospice home care. Journal of Hospice and Palliative Nursing, 11(1), 41-51. doi:10.1097/NJH.0b013e3181917d7a
McMillan, S. C., & Small, B. (2002). Symptom distress and quality of life in hospice patients with cancer newly admitted to hospice home care. Oncology Nursing Forum, 29, 1421-1428. doi:10.1188/02.ONF.1421-1428
McMillan, S. C., Small, B. J., Weitzner, M., Schonwetter, R., Tittle, M., Moody, L., & Haley, W. E. (2006). Impact of coping skills intervention with family caregivers of hospice patients with cancer: A randomized clinical trial. Cancer, 106, 214-222. doi:10.1002/cncr.21567
McMillan, S. C., Tittle, M., Hagan, S., & Laughlin, J. (2000). Management of pain and pain-related symptoms in hospitalized veterans with cancer. Cancer Nursing, 23, 327-336. doi:10.1097/00002820-200010000-00001
McMillan, S. C., & Williams, F. A. (1989). Validity and reliability of the Constipation Assessment Scale. Cancer Nursing, 12, 183-188. doi:10.1097/00002820-198906000-00012
Miaskowski, C. (1995). Putting the cancer pain guidelines into practice. Capsules and Comments in Oncology Nursing, 3(1), 9-15.
Murphy, D. B., Sutton, J. A., Prescott, L. F., & Murphy, M. B. (1997). Opioid-induced delay in gastric emptying: A peripheral mechanism in humans. Anesthesiology, 87, 765-770. doi:10.1097/00000542-199710000-00008
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649-655. doi:10.1097/00000421-198212000-00014
Pfeiffer, E. (1975). A Short Portable Mental Status Questionnaire for the assessment of organic brain deficit in elderly patients. Journal of American Geriatrics Society, 23, 433-441.
Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., … Norton, L. (1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A, 1326-1336. doi:10.1016/0959-8049(94)90182-1
Schulman-Green, D., Jaser, S., Martin, F., Alonzo, A., Grey, M., McCorkle, R., … Whittemore, R. (2012). Processes of self-management in chronic illness. Journal of Nursing Scholarship, 44, 136-144. doi:10.1111/j.1547-5069.2012.01444.x
Singer, J. D., & Willett, J. B. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York, NY: Oxford University Press.
Thomas, J., Karver, S., Cooney, G. A., Chamberlain, B. H., Watt, C. K., Slatkin, N. E., … Israel, R. J. (2008). Methylnaltrexone for opioid-induced constipation in advanced illness. New England Journal of Medicine, 358, 2332-2343. doi:10.1056/NEJMoa0707377
Tittle, M., & McMillan, S. C. (1994). Pain and pain-related side effects in an ICU and on a surgical unit: Nurses' management. American Journal of Critical Care, 3(1), 25-30.
Wilkes, G. M., Ingwersen, K., & Barton-Burke, M. (2001). Oncology nursing drug handbook. Boston, MA: Jones and Bartlett.
Woolery, M., Bisanz, A., Lyons, H. F., Gaido, L., Yenulevich, M., Fulton, S., & McMillan, S. C. (2008). Putting evidence into practice: Evidence-based interventions for the prevention and management of constipation in cancer patients. Journal of Clinical Oncology, 7, 317-337.
Woolery, M., Carroll, E., Fenn, E., Wieland, H., Jarosinski, P., Corey, B., & Wallen, G. R. (2006). A constipation assessment scale for use in pediatric oncology. Journal of Pediatric Oncology Nursing, 23, 65-74. doi:10.1177/1043454205285874
Zarit, S., & Zarit, J. (1998). Mental disorders in older adults: Fundamentals of assessment and treatment. New York, NY: Guilford Press.